217 related articles for article (PubMed ID: 20736080)
1. Mycophenolic acid inhibits natural killer cell proliferation and cytotoxic function: a possible disadvantage of including mycophenolate mofetil in the graft-versus-host disease prophylaxis regimen.
Ohata K; Espinoza JL; Lu X; Kondo Y; Nakao S
Biol Blood Marrow Transplant; 2011 Feb; 17(2):205-13. PubMed ID: 20736080
[TBL] [Abstract][Full Text] [Related]
2. Natural Killer Cell Activating Receptor NKG2D Is Involved in the Immunosuppressive Effects of Mycophenolate Mofetil and Hepatitis B Virus Infection.
Dong S; Geng L; Shen MD; Zheng SS
Am J Med Sci; 2015 May; 349(5):432-7. PubMed ID: 25828197
[TBL] [Abstract][Full Text] [Related]
3. In-vitro influence of mycophenolate mofetil (MMF) and Ciclosporin A (CsA) on cytokine induced killer (CIK) cell immunotherapy.
Bremm M; Huenecke S; Zimmermann O; Pfirrmann V; Quaiser A; Bonig H; Soerensen J; Klingebiel T; Rettinger E; Bader P; Cappel C
J Transl Med; 2016 Sep; 14(1):264. PubMed ID: 27620209
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine model.
Shapira MY; Hirshfeld E; Weiss L; Zeira M; Kasir J; Or R; Resnick IB; Slavin S
Cancer Immunol Immunother; 2005 Apr; 54(4):383-8. PubMed ID: 15692848
[TBL] [Abstract][Full Text] [Related]
5. The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations.
Wang H; Grzywacz B; Sukovich D; McCullar V; Cao Q; Lee AB; Blazar BR; Cornfield DN; Miller JS; Verneris MR
Blood; 2007 Sep; 110(5):1530-9. PubMed ID: 17495133
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.
Quéméneur L; Flacher M; Gerland LM; Ffrench M; Revillard JP; Bonnefoy-Berard N
J Immunol; 2002 Sep; 169(5):2747-55. PubMed ID: 12193749
[TBL] [Abstract][Full Text] [Related]
7. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
Allison AC; Eugui EM
Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of mycophenolate mofetil and cyclosporine A on peripheral blood and cord blood natural killer cells activated with interleukin-2.
Derniame S; Perazzo J; Lee F; Domogala A; Escobedo-Cousin M; Alnabhan R; Luevano M; Pedroza-Pacheco I; Cooper N; Madrigal A; Saudemont A
Cytotherapy; 2014 Oct; 16(10):1409-18. PubMed ID: 24969967
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2-stimulated natural killer cells are less susceptible to mycophenolate mofetil than non-activated NK cells: possible consequences for immunotherapy.
Brehm C; Huenecke S; Esser R; Kloess S; Quaiser A; Betz S; Zimmermann O; Soerensen J; Passweg JR; Klingebiel T; Schwabe D; Bader P; Koehl U
Cancer Immunol Immunother; 2014 Aug; 63(8):821-33. PubMed ID: 24806448
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin and MPA, but not CsA, impair human NK cell cytotoxicity due to differential effects on NK cell phenotype.
Eissens DN; Van Der Meer A; Van Cranenbroek B; Preijers FW; Joosten I
Am J Transplant; 2010 Sep; 10(9):1981-90. PubMed ID: 20883533
[TBL] [Abstract][Full Text] [Related]
11. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
Lin SJ; Kuo ML
Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
[TBL] [Abstract][Full Text] [Related]
12. Delay expression of NKp30 on NK cells correlates with long-term mycophenolate mofetil treatment and higher EBV viremia post allogenic hematological stem cells transplantation.
Yu XX; Cao XH; Yan H; Luo XY; Zhao XS; Sun YQ; Wang Y; Xu LP; Zhang XH; Chang YJ; Huang XJ; Zhao XY
Clin Immunol; 2019 Aug; 205():49-56. PubMed ID: 31112757
[TBL] [Abstract][Full Text] [Related]
13. Effect of mTOR Inhibition with Sirolimus on Natural Killer Cell Reconstitution in Allogeneic Stem Cell Transplantation.
Haroun-Izquierdo A; Lanuza PM; Pfefferle A; Netskar H; Ask EH; Törlén J; Björklund A; Sohlberg E; Malmberg KJ
Transplant Cell Ther; 2023 Jun; 29(6):376.e1-376.e11. PubMed ID: 36966873
[TBL] [Abstract][Full Text] [Related]
14. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
15. WITHDRAWN: Natural Killer Cell Activating Receptor NKG2D Is Involved in the Immunosuppressant Effect of Mycophenolate Mofetil and Infection of Hepatitis B Virus.
Dong S; Geng L; Shen MD; Zheng SS
Transplant Proc; 2015; 47(6):1796-801. PubMed ID: 26293053
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo lymphocyte proliferative function is severely inhibited in renal transplant patients on mycophenolate mofetil treatment.
Hutchinson P; Jose M; Atkins RC; Holdsworth SR
Transpl Immunol; 2004; 13(1):55-61. PubMed ID: 15203129
[TBL] [Abstract][Full Text] [Related]
17. Added effects of dexamethasone and mesenchymal stem cells on early Natural Killer cell activation.
Michelo CM; Fasse E; van Cranenbroek B; Linda K; van der Meer A; Abdelrazik H; Joosten I
Transpl Immunol; 2016 Jul; 37():1-9. PubMed ID: 27142560
[TBL] [Abstract][Full Text] [Related]
18. An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients.
Bhatia M; Militano O; Jin Z; Figurski M; Shaw L; Moore V; Morris E; Tallamy B; van deVen C; Ayello J; Baxter-Lowe L; Satwani P; George D; Bradley MB; Garvin J; Cairo MS
Biol Blood Marrow Transplant; 2010 Mar; 16(3):333-43. PubMed ID: 19835971
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels.
Boyiadzis M; Memon S; Carson J; Allen K; Szczepanski MJ; Vance BA; Dean R; Bishop MR; Gress RE; Hakim FT
Biol Blood Marrow Transplant; 2008 Mar; 14(3):290-300. PubMed ID: 18275895
[TBL] [Abstract][Full Text] [Related]
20. Unique effects of mycophenolate mofetil on cord blood T cells: implications for GVHD prophylaxis.
Derniame S; Lee F; Domogala A; Madrigal A; Saudemont A
Transplantation; 2014 Apr; 97(8):870-8. PubMed ID: 24670298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
